Category: Psychedelic Bulletin - Page 6 - Psychedelic Alpha

Read more about the article Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of Maryland Joins Terran’s Complaint Against Compass

Pα+ Psychedelic Bulletin #156: Canada’s First Published Psilocybin Trial; University of Maryland Joins Terran’s Complaint Against Compass

Post published:February 19, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #155: MAPS Invests in Numinus, Hopes to Offer Experiential Training for MDMA Therapists

Pα+ Psychedelic Bulletin #155: MAPS Invests in Numinus, Hopes to Offer Experiential Training for MDMA Therapists

Post published:February 8, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #154: Public & Industry Respond to DEA’s Renewed DOI and DOC Scheduling Plan; TARA Mind Scores $8m Seed; Updates on State Psychedelics Programs

Pα+ Psychedelic Bulletin #154: Public & Industry Respond to DEA’s Renewed DOI and DOC Scheduling Plan; TARA Mind Scores $8m Seed; Updates on State Psychedelics Programs

Post published:January 26, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #153: MindMed Scraps Microdosing Program; Eagerly Anticipated Ibogaine Study Publishes; Compass Collaborates with Greenbrook; Gilgamesh’s GM-1020 Readout; and more…

Pα+ Psychedelic Bulletin #153: MindMed Scraps Microdosing Program; Eagerly Anticipated Ibogaine Study Publishes; Compass Collaborates with Greenbrook; Gilgamesh’s GM-1020 Readout; and more…

Post published:January 12, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Psychedelic Bulletin #152: Policy and Business Updates

Psychedelic Bulletin #152: Policy and Business Updates

Post published:December 22, 2023
Post category:Psychedelic Bulletin

Read more about the article Pα+ Psychedelic Bulletin #151: Psilocybin for BDII, ACNP Readouts, Methylone for PTSD, and More Psychedelic Drug Dev. News

Pα+ Psychedelic Bulletin #151: Psilocybin for BDII, ACNP Readouts, Methylone for PTSD, and More Psychedelic Drug Dev. News

Post published:December 14, 2023
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates

Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates

Post published:November 29, 2023
Post category:Psychedelic Bulletin Pα+

Read more about the article Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments

Pα+ Psychedelic Bulletin #149: Worldwide Psychedelic Policy Developments

Post published:November 17, 2023
Post category:Psychedelic Bulletin Pα+

Read more about the article Psychedelic Bulletin #148 (Pα+)

Psychedelic Bulletin #148 (Pα+)

Post published:November 3, 2023
Post category:Psychedelic Bulletin Pα+

Read more about the article Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more

Psychedelic Bulletin #147: Newsom Vetoes Psychedelic Decrim. in CA; At-Home Ketamine Gets a Lifeline and a Warning; Drug Development Updates from GH, atai, Cybin; and more

Post published:October 17, 2023
Post category:Psychedelic Bulletin

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.